EXHIBIT 99.1

Sun Healthcare Group, Inc.

Reports First-Quarter Earnings;

Strongest First Quarter to Date

Contact: Investor Inquiries (505) 468-2341

Media Inquiries (505) 468-4582

Irvine, Calif. (April 28, 2009)--Sun Healthcare Group, Inc. (NASDAQ GS: SUNH) today announced results for the first quarter ended March 31, 2009.

Consolidated Results - First Quarter

     Total net revenue for the quarter ended March 31, 2009, was $468.3 million, up 4.0 percent compared to $450.4 million for the comparable period one year ago. Net income for the quarter ended March 31, 2009, was $10.2 million, compared to net income of $8.6 million for the comparable 2008 period. Diluted earnings per share for the quarter ended March 31, 2009, was $0.23 compared to $0.19 for the comparable period one year ago. The table below shows results of operations for the quarters ended March 31, 2009 and 2008, including certain normalized items that have been adjusted as discussed following the table.

(Dollars in thousands)	Quarter Ended March 31,
	2009			2008
Revenue	$	468,296		$	450,369
Depreciation and amortization		10,723			9,607
Interest expense, net		12,726			14,431
Pre-tax income		19,656			13,490
Income tax expense		8,059			5,388
Income from continuing operations		11,597			8,102
(Loss) income from discontinued operations		(1,354	)		475
Net income	$	10,243		$	8,577
Diluted earnings per share	$	0.23		$	0.19
EBITDAR	$	61,520		$	55,892
Margin - EBITDAR		13.1	%		12.4	%
EBITDAR normalized	$	61,520		$	57,361
Margin - EBITDAR normalized		13.1	%		12.7	%
EBITDA	$	43,105		$	37,451
Margin - EBITDA		9.2	%		8.3	%
EBITDA normalized	$	43,105		$	38,920
Margin - EBITDA normalized		9.2	%		8.6	%
Pre-tax income continuing operations - normalized	$	19,656		$	14,959
Income tax expense - normalized	$	8,059		$	5,976
Income from continuing operations - normalized	$	11,597		$	8,983
Diluted earnings per share - normalized	$	0.26		$	0.20
Net income - normalized	$	10,243		$	9,458
Diluted earnings per share - normalized	$	0.23		$	0.21

There were no normalizing adjustments for the quarter ended March 31, 2009. During the quarter, we incurred non-recurring costs of $0.9 million associated with the implementation of a new clinical/billing platform and a labor management system, but made no normalizing adjustments for these costs. Normalized results for the quarter ended March 31, 2008, include a $1.5 million pre-tax charge related to integration costs associated with the acquisition of Harborside Healthcare Corporation in 2007.

On a normalized basis, comparing the quarter ended March 31, 2009, to the same period in 2008:

·   revenue increased $17.9 million, or 4.0 percent;

·   EBITDAR increased $4.2 million, or 7.3 percent;

·   EBITDAR margin improved 40 basis points to 13.1 percent;

·   EBITDA increased $4.2 million, or 10.8 percent;

·   EBITDA margin improved 60 basis points to 9.2 percent; and

·   income from continuing operations increased by $2.6 million, or 29.1 percent.

Commenting on the results, Richard K. Matros, Sun’s chairman and chief executive officer, stated, “We continue to achieve positive financial results in challenging economic times by generating four-percent top line growth and solid margin improvement in the quarter.  Furthermore, eliminating $5.3 million of revenues resulting from the extra revenue day in 2008, which was a leap year, and the corresponding $1.2 million EBITDA contribution, so that the year-over-year comparison is for the same number of days, we had five percent revenue growth and our EBITDA margin grew 70 basis points. Our deleveraging efforts in the quarter were significant as we reduced our long-term debt by $19.6 million through principal payments. I am also pleased with our continued strong liquidity position which, at the end of the quarter, was $150 million, comprised of $100 million in cash coupled with our $50 million undrawn revolving credit facility.”

Inpatient Business

For our core inpatient business, comparing the quarters ended March 31, 2009 and 2008, on a normalized basis:

·   revenue increased $16.4 million, or 4.1 percent, to $415.4 million from $399.0 million;

·   net segment EBITDAR increased $4.0 million, or 5.8 percent, to $72.8 million from $68.8 million;

·   net segment EBITDAR margin for 2009 was 17.5 percent compared to 17.2 percent in 2008;

·   net segment EBITDA increased $4.0 million, or 7.9 percent, to $54.7 million from $50.7 million;

·   net segment EBITDA margin for 2009 was 13.2 percent compared to 12.7 percent in 2008;

·   rehabilitation RUGS utilization increased 400 basis points to 88.2 percent as a percent of total Medicare days; and

·   Rehabilitation Extensive Service (“REX”) days as a percent of total Medicare days was 41.2 percent, up 60 basis points from the same period in 2008.

The revenue gain of $16.4 million in the quarter was primarily attributable to:

·   an $8.6 million increase in Medicare revenue due principally to Medicare part A rate growth and part B volume growth;

·   a $4.4 million increase in managed care/commercial insurance revenue due to a higher customer base coupled with rate growth;

·   a $2.4 million increase in Medicaid revenue resulting from a $3.7 million rate improvement partially offset by a $1.3 million impact from a decrease in customer base;

·   a $3.0 million increase in hospice revenue due to both internal growth and a September 2008 hospice acquisition; and

·   a $2.2 million decrease in private and other revenue due principally to a decline in customer base.

Matros further stated, “I am pleased with the results achieved from the acuity shift in our skilled nursing beds. Our skilled mix at quarter-end was 20.8 percent, our highest to date. We continue to combat contraction in Medicaid rates and I am pleased to report our overall dependency on Medicaid declined in the quarter by 130 basis points sequentially to 43.7 percent, a new reported low for the company. In addition to skilled mix growth, our Rehab Recovery Suites® (“RRS”) continue to be a growth driver for the company. We currently have 48 centers with an RRS unit and we remain on target to have approximately 70 centers with an RRS unit by the end of 2009.”

Ancillary Businesses

For our ancillary businesses comparing the quarters ended March 31, 2009 and 2008:

·   revenue increased $5.5 million, or 8.3 percent, to $71.7 million from $66.2 million;

·   EBITDA increased $0.8 million, or 19.4 percent, to $5.2 million from $4.4 million; and

·   EBITDA margin for 2009 was 7.3 percent compared to 6.6 percent in 2008.

Conference Call

Sun invites investors to listen to a conference call with Sun’s senior management on Wednesday, April 29, 2009, at 10 a.m. Pacific / 1 p.m. Eastern, to discuss the Company’s first-quarter earnings for 2009.

To listen to the conference call, dial (877) 719-9799 and refer to Sun Healthcare Group. A recording of the call will be available from 4 p.m. Eastern on April 29, 2009, until midnight Eastern on May 29, 2009, by calling (888) 203-1112 and using access code 2900481.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc., with executive offices in Irvine, California, owns SunBridge Healthcare Corporation and other affiliated companies that operate healthcare centers in many states. In addition, the Sun Healthcare Group family of companies provides therapy through SunDance Rehabilitation Corporation, hospice services through SolAmor Hospice and medical staffing through CareerStaff Unlimited, Inc.

Statements made in this release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "anticipate," "believe," "plan," "estimate,” "expect," "hope,” "intend," "may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by the company with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements; our ability to maintain the occupancy rates and payor mix at our healthcare centers; potential liability for losses not covered by, or in excess of, our insurance; the effects of government regulations and investigations; the significant amount of our indebtedness, covenants in our debt agreements that may restrict our activities and our ability to incur more indebtedness; the impact of the current economic downturn on our business; increasing labor costs and the shortage of qualified healthcare personnel; and our ability to receive increases in reimbursement rates from government payors to cover increased costs. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Forms 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com.

     The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments. EBITDA and EBITDAR as used in this press release, and EBITDAM and EBITDARM as used in the accompanying tables, which are non-GAAP financial measures, are each reconciled to net income (loss) in the accompanying tables. In addition, the normalizing adjustments to EBITDA, EBITDAR, pre-tax income and income from continuing operations discussed in this press release and shown in the accompanying tables are non-GAAP adjustments.

     Any documents filed by Sun with the SEC may be obtained free of charge at the SEC’s web site at www.sec.gov. In addition, investors and stockholders of Sun may obtain free copies of the documents filed with the SEC by contacting Sun’s investor relations department at (505) 468-2341 (TDD users, please call (505) 468-4458) or by sending a written request to Investor Relations, Sun Healthcare Group, Inc. 101 Sun Avenue N.E., Albuquerque, N.M. 87109. You may also read and copy any reports, statements and other information filed by Sun with the SEC at the SEC public reference room at Room 1580, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at (800) SEC-0330 or visit the SEC’s web site for further information.

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
	March 31, 2009			December 31, 2008
	(unaudited)			(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	99,945		$	92,153
Restricted cash		26,568			34,676
Accounts receivable, net		211,552			205,620
Prepaid expenses and other assets		22,200			21,456
Assets held for sale		959			3,654
Deferred tax assets		57,705			57,261
Total current assets		418,929			414,820
Property and equipment, net		605,500			603,645
Intangible assets, net		52,839			54,388
Goodwill		326,957			326,808
Restricted cash, non-current		3,305			3,303
Deferred tax assets		128,189			134,807
Other assets		5,097			5,563
Total assets	$	1,540,816		$	1,543,334
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	58,681		$	62,000
Accrued compensation and benefits		64,938			60,660
Accrued self-insurance obligations, current		46,527			45,293
Other accrued liabilities		61,469			56,857
Current portion of long-term debt and capital lease obligations		8,225			17,865
Total current liabilities		239,840			242,675
Accrued self-insurance obligations, net of current portion		114,230			114,557
Long-term debt and capital lease obligations, net of current portion		698,061			707,976
Unfavorable lease obligations, net		14,807			15,514
Other long-term liabilities		59,082			58,903
Total liabilities		1,126,020			1,139,625
Stockholders' equity:
Preferred stock of $.01 par value, authorized 10,000,000 shares,       no shares were issued and outstanding as of      March 31, 2009 and December 31, 2008		-			-
Common stock of $.01 par value, authorized 125,000,000 shares,       43,548,765 and 43,544,765 shares issued and outstanding       as of March 31, 2009 and December 31, 2008, respectively		435			435
Additional paid-in capital		651,455			650,543
Accumulated deficit		(232,439	)		(242,683	)
Accumulated other comprehensive loss, net		(4,655	)		(4,586	)
		414,796			403,709
Total liabilities and stockholders' equity	$	1,540,816		$	1,543,334

1 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
INCOME STATEMENTS
(in thousands, except per share data)
	For the			For the
	Three Months Ended			Three Months Ended
	March 31, 2009			March 31, 2008
	(unaudited)			(unaudited)
Total net revenues	$	468,296		$	450,369
Costs and expenses:
Operating salaries and benefits		262,984			254,932
Self-insurance for workers' compensation and       general and professional liability insurance		14,659			14,774
Operating administrative costs		12,577			11,936
Other operating costs		95,819			92,941
Center rent expense		18,415			18,441
General and administrative expenses		16,750			16,586
Depreciation and amortization		10,723			9,607
Provision for losses on accounts receivable		3,987			3,308
Interest, net of interest income of $108 and $545, respectively		12,726			14,431
Gain on sale of assets, net		-			(77	)
Total costs and expenses		448,640			436,879
Income before income taxes and discontinued operations		19,656			13,490
Income tax expense		8,059			5,388
Income from continuing operations		11,597			8,102
Discontinued operations:
(Loss) income from discontinued operations, net of related taxes		(1,046	)		537
Loss on disposal of discontinued operations, net of related taxes		(308	)		(62	)
(Loss) income from discontinued operations, net		(1,354	)		475
Net income	$	10,243		$	8,577
Basic income per common and common equivalent share:
Income from continuing operations	$	0.27		$	0.19
(Loss) income from discontinued operations, net		(0.04	)		0.01
Net income	$	0.23		$	0.20
Diluted income per common and common equivalent share:
Income from continuing operations	$	0.26		$	0.18
(Loss) income from discontinued operations, net		(0.03	)		0.01
Net Income	$	0.23		$	0.19
Weighted average number of common and   common equivalent shares outstanding:
Basic		43,643			43,067
Diluted		43,872			44,474

2 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
	For the			For the
	Three Months Ended			Three Months Ended
	March 31, 2009			March 31, 2008
	(unaudited)			(unaudited)
Cash flows from operating activities:
Net income	$	10,243		$	8,577
Adjustments to reconcile net income to net cash provided by
operating activities, including discontinued operations:
Depreciation and amortization		10,723			9,717
Amortization of favorable and unfavorable lease intangibles		(401	)		(503	)
Provision for losses on accounts receivable		3,987			3,301
Loss (gain) on sale of assets, including discontinued operations, net		523			(15	)
Stock-based compensation expense		1,268			965
Deferred taxes		6,174			1,829
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(10,068	)		(16,040	)
Restricted cash		8,106			5
Prepaid expenses and other assets		154			(3,416	)
Accounts payable		(3,536	)		(1,403	)
Accrued compensation and benefits		4,273			1,062
Accrued self-insurance obligations		907			2,033
Income taxes payable		-			470
Other accrued liabilities		4,743			6,432
Other long-term liabilities		297			1,785
Net cash provided by operating activities		37,393			14,799
Cash flows from investing activities:
Capital expenditures		(11,865	)		(5,916	)
Proceeds from sale of assets held for sale		2,174			3,777
Acquisitions, net of cash acquired		-			(307	)
Net cash used for investing activities		(9,691	)		(2,446	)
Cash flows from financing activities:
Principal repayments of long-term debt and capital lease obligations		(19,612	)		(3,084	)
Payment to non-controlling interest		-			(2,035	)
Distribution to non-controlling interest		(311	)		(223	)
Proceeds from issuance of common stock		13			39
Net cash used for financing activities		(19,910	)		(5,303	)
Net increase in cash and cash equivalents		7,792			7,050
Cash and cash equivalents at beginning of period		92,153			55,832
Cash and cash equivalents at end of period	$	99,945		$	62,882

3 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO EBITDA(M) and EBITDAR(M)
(in thousands)
	For the		For the
	Three Months Ended		Three Months Ended
	March 31, 2009		March 31, 2008
	(unaudited)		(unaudited)
Total net revenues	$	468,296	$	450,369
Net income	$	10,243	$	8,577
Income from continuing operations		11,597		8,102
Income tax expense		8,059		5,388
Gain on sale of assets, net		-		(77	)
Net segment income	$	19,656	$	13,413
Interest, net		12,726		14,431
Depreciation and amortization		10,723		9,607
EBITDA	$	43,105	$	37,451
Center rent expense		18,415		18,441
EBITDAR	$	61,520	$	55,892
Operating administrative costs		12,577		11,936
General and administrative expenses		16,750		16,586
Total operating and general and admin expenses		29,327		28,522
EBITDAM	$	72,432	$	65,973
EBITDARM	$	90,847	$	84,414

EBITDA is defined as earnings before income (loss) on discontinued operations, income taxes, loss (gain) on sale of assets, net, interest, net, depreciation and amortization.   EBITDAM is defined as EBITDA before operating and general and administrative expenses.  EBITDAR is defined as EBITDA before facility rent expense.  EBITDARM is defined as EBITDAR before operating and general and administrative expenses.  EBITDA, EBITDAM, EBITDAR and EBITDARM are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole.  EBITDA, EBITDAM, EBITDAR and EBITDARM are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA, EBITDAM, EBITDAR and EBITDARM should not be considered as measures of financial performance under generally accepted accounting principles.  As the items excluded from EBITDA, EBITDAM, EBITDAR and EBITDARM are significant components in understanding and assessing financial performance, EBITDA, EBITDAM, EBITDAR and EBITDARM should not be considered in isolation or as alternatives to net income (loss), cash flows generated by or used in operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Because EBITDA, EBITDAM, EBITDAR and EBITDARM are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA, EBITDAM, EBITDAR and EBITDARM as presented may not be comparable to other similarly titled measures of other companies.

4 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA(M) and EBITDAR(M)
($ in thousands)
For the Three Months Ended March 31, 2009
(unaudited)
	Inpatient Services			Rehabilitation Therapy Services			Medical Staffing Services			Other & Corp Seg			Elimination of Affiliated Revenue			Consolidated
Nonaffiliated revenue	$	415,402		$	25,516		$	27,374		$	4		$	-		$	468,296
Affiliated revenue		-			18,216			560			-			(18,776	)		-
Total revenue		415,402			43,732			27,934			4			(18,776	)		468,296
Net segment income (loss)	$	41,789		$	2,889		$	2,021		$	(27,043	)	$	-		$	19,656
Interest, net		3,209			(1	)		1			9,517			-			12,726
Depreciation and amortization		9,728			128			190			677			-			10,723
EBITDA	$	54,726		$	3,016		$	2,212		$	(16,849	)	$	-		$	43,105
Center rent expense		18,056			115			244			-			-			18,415
EBITDAR	$	72,782		$	3,131		$	2,456		$	(16,849	)	$	-		$	61,520
Operating and general and   administrative expenses		9,864			1,916			797			16,750			-			29,327
EBITDAM	$	64,590		$	4,932		$	3,009		$	(99	)	$	-		$	72,432
EBITDARM	$	82,646		$	5,047		$	3,253		$	(99	)	$	-		$	90,847
EBITDA margin		13.2	%		6.9	%		7.9	%								9.2	%
EBITDAM margin		15.5	%		11.3	%		10.8	%								15.5	%
EBITDAR margin		17.5	%		7.2	%		8.8	%								13.1	%
EBITDARM margin		19.9	%		11.5	%		11.6	%								19.4	%
See definitions of EBITDA and EBITDAR in the table "Reconciliation of Net Income to EBITDA(M) and EBITDAR(M)."

5 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA(M) and EBITDAR(M)
($ in thousands)
For the Three Months Ended March 31, 2008
(unaudited)
	Inpatient Services			Rehabilitation Therapy Services			Medical Staffing Services			Other & Corp Seg			Elimination of Affiliated Revenue			Consolidated
Nonaffiliated revenue	$	398,980		$	21,710		$	29,668		$	11		$	-		$	450,369
Affiliated revenue		-			14,291			533			-			(14,824	)		-
Total revenue		398,980			36,001			30,201			11			(14,824	)		450,369
Net segment income (loss)	$	37,843		$	2,128		$	1,932		$	(28,490	)	$	-		$	13,413
Interest, net		3,318			-			(1	)		11,114			-			14,431
Depreciation and amortization		8,599			126			195			687			-			9,607
EBITDA	$	49,760		$	2,254		$	2,126		$	(16,689	)	$	-		$	37,451
Center rent expense		18,107			86			248			-			-			18,441
EBITDAR	$	67,867		$	2,340		$	2,374		$	(16,689	)	$	-		$	55,892
Operating and general and   administrative expenses		9,509			1,617			811			16,585			-			28,522
EBITDAM	$	59,269		$	3,871		$	2,937		$	(104	)	$	-		$	65,973
EBITDARM	$	77,376		$	3,957		$	3,185		$	(104	)	$	-		$	84,414
EBITDA margin		12.5	%		6.3	%		7.0	%								8.3	%
EBITDAM margin		14.9	%		10.8	%		9.7	%								14.6	%
EBITDAR margin		17.0	%		6.5	%		7.9	%								12.4	%
EBITDARM margin		19.4	%		11.0	%		10.5	%								18.7	%
See definitions of EBITDA and EBITDAR in the table "Reconciliation of Net Income to EBITDA(M) and EBITDAR(M)."

6 of 8

Sun Healthcare Group, Inc. and Subsidiaries
Selected Operating Statistics
Continuing Operations
	For the
	Three Months Ended
	March 31,
	2009					2008
Consolidated Company
Revenues - Non-affiliated (in thousands)
Inpatient Services	$	415,402				$	398,980
Rehabilitation Therapy Services		25,516					21,710
Medical Staffing Services		27,374					29,668
Other - non-core businesses		4					11
Total	$	468,296				$	450,369
Revenue Mix - Non-affiliated (in thousands)
Medicare	$	141,876		30	%	$	129,158		29	%
Medicaid		181,451		39	%		178,917		40	%
Private and Other		114,664		24	%		116,730		25	%
Managed Care / Insurance		26,409		6	%		22,023		5	%
Veterans		3,896		1	%		3,541		1	%
Total	$	468,296		100	%	$	450,369		100	%
Inpatient Services Stats
Number of centers:		207					207
Number of available beds:		22,511					22,524
Occupancy %:		88.7	%				89.5	%
Payor Mix % based on patient days:
Medicare - SNF Beds		16.5	%				16.7	%
Managed care / Ins. - SNF Beds		4.3	%				3.8	%
Total SNF skilled mix		20.8	%				20.5	%
Medicare		15.0	%				15.1	%
Medicaid		59.8	%				59.1	%
Private and Other		20.3	%				21.4	%
Managed Care / Insurance		3.9	%				3.5	%
Veterans		1.0	%				0.9	%
Revenue Mix % of revenues:
Medicare - SNF Beds		33.8	%				32.8	%
Managed care / Ins. - SNF Beds		6.7	%				5.8	%
Total SNF skilled mix		40.5	%				38.6	%
Medicare		33.2	%				31.7	%
Medicaid		43.7	%				44.8	%
Private and Other		15.9	%				17.1	%
Managed Care / Insurance		6.3	%				5.5	%
Veterans		0.9	%				0.9	%
Revenues PPD:
LTC only Medicare (Part A)	$	450.47				$	412.91
Medicare Blended Rate (Part A & B)	$	485.72				$	441.76
Medicaid	$	168.71				$	165.06
Private and Other	$	176.28				$	169.55
Managed Care / Insurance	$	373.93				$	342.93
Veterans	$	220.02				$	208.80
Rehab contracts
Affiliated		120					106
Non-affiliated		331					312

7 of 8

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NORMALIZING ADJUSTMENTS - 1st QUARTER COMPARISON
(in thousands, except per share data)
	AS REPORTED - 1st QUARTER 2009
	Revenue		EBITDAR			EBITDA			Pre-tax			Income from Continuing Operations			Disc Ops			Net Income
As Reported 1st QUARTER 2009	$	468,296	$	61,520		$	43,105		$	19,656		$	11,597		$	(1,354	)	$	10,243
Percent of Revenue				13.1	%		9.2	%		4.2	%		2.5	%		-0.3	%		2.2	%
Normalizing Adjustments:
None		-		-			-			-			-			-			-
Adjusted As Reported-1st QUARTER 2009	$	468,296	$	61,520		$	43,105		$	19,656		$	11,597		$	(1,354	)	$	10,243
Percent of Revenue				13.1	%		9.2	%		4.2	%		2.5	%		-0.3	%		2.2	%
As Reported												$	0.26		$	(0.03	)	$	0.23
Diluted EPS:      As Adjusted												$	0.26		$	(0.03	)	$	0.23
	AS REPORTED - 1st QUARTER 2008
	Revenue		EBITDAR			EBITDA			Pre-tax			Income from Continuing Operations			Disc Ops			Net Income
As Reported - 1st QUARTER 2008	$	450,369	$	55,892		$	37,451		$	13,490		$	8,102		$	475		$	8,577
Percent of Revenue				12.4	%		8.3	%		3.0	%		1.8	%		0.1	%		1.9	%
Normalizing Adjustments:
Harborside integration costs		-		1,469			1,469			1,469			881			-			881
Adjusted As Reported - 1st QUARTER 2008	$	450,369	$	57,361		$	38,920		$	14,959		$	8,983		$	475		$	9,458
Percent of Revenue				12.7	%		8.6	%		3.3	%		2.0	%		0.1	%		2.1	%
As Reported												$	0.18		$	0.01		$	0.19
Diluted EPS:      As Adjusted												$	0.20		$	0.01		$	0.21
See definitions of EBITDA and EBITDAR in the table "Reconciliation of Net Income to EBITDA(M) and EBITDAR(M)."
Normalizing adjustments are transactions or adjustments not related to ongoing operations, including integration costs related to the Harborside acquisition.
Since normalizing adjustments are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations and interpretations, the information presented herein may not be comparable to other similarly described information of other companies.

8 of 8